The Benztropine Mesylate Injection, cataloged under National Stock Number 6505-01-710-5819, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-710-5819 |
| Primary Part Number | NDC63323-0970-02 |
| Item Name | Benztropine Mesylate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 2.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0970-02 PRIMARY | Fresenius Kabi, Llc (USA) |
| NDC68382-0860-10 PRIMARY | Zydus Pharmaceuticals (usa) Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1651750 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM239053 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-710-5819 is a Benztropine Mesylate Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-710-5819 has 2 manufacturer part numbers on file: NDC63323-0970-02 (Fresenius Kabi, Llc), NDC68382-0860-10 (Zydus Pharmaceuticals (usa) Inc.).
Key specifications for NDC63323-0970-02: Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 2.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.